Capecitabine for the treatment of advanced gastric cancer

TA191 Gastric cancer (advanced) - capecitabine: review decision - July 2013 information

TA191 Gastric cancer (advanced) - capecitabine: Appendix A decision paper presented to the Institute's Guidance Executive

TA191 Gastric cancer (advanced) - capecitabine: Appendix A decision paper presented to the Institute's Guidance Executive (PDF 99 KB)

TA191 Gastric cancer (advanced) - capecitabine: Review Proposal - May 2013 information

TA191 Gastric cancer (advanced) - capecitabin: Appendix A - provisional matrix of stakeholders

TA191 Gastric cancer (advanced) - capecitabin: Appendix A - provisional matrix of stakeholders (PDF 97 KB)

TA191 Gastric cancer (advanced) - capecitabine: Appendix B - proposal paper presented to the Institute's Guidance Executive

Gastric cancer (advanced) capecitabine: final appraisal determination information

Gastric cancer (advanced) capecitabine: final appraisal determination

Gastric cancer (advanced) capecitabine: final appraisal determination (PDF 213 KB)

Gastric cancer (advanced) capecitabine: pre meeting briefing

Gastric cancer (advanced) capecitabine: pre meeting briefing (PDF 158 KB)

Gastric cancer (advanced) capecitabine: evidence review group report

Evidence review group's report

Evidence review group's report (PDF 2.07 MB)

Evidence review group's responses to proforma comments

Evidence review group's responses to proforma comments (PDF 20 KB)

Gastric cancer (advanced) capecitabine: non-manufacturer submissions

Royal College of Physicians

Royal College of Physicians (PDF 58 KB)

Royal College of Nursing

Royal College of Nursing (PDF 11 KB)

Gastric cancer (advanced) capecitabine: manufacturer submission - Roche

Gastric cancer (advanced) capecitabine: manufacturer submission - Roche (PDF 1.05 MB)

Gastric cancer (advanced) capecitabine: clarification letters

NICE clarification letter

NICE clarification letter (PDF 66 KB)

Manufacturer response to clarification letter

Manufacturer response to clarification letter (PDF 470 KB)

Gastric cancer (advanced) capecitabine: expert written personal statements

Dr Alicia Okines, Clinical Research Fellow in gastrointestinal oncology - nominated by the Royal College of Physicians

Dr Alicia Okines, Clinical Research Fellow in gastrointestinal oncology - nominated by the Royal College of Physicians (PDF 389 KB)

Dr Anne Thomas, Senior Lecturer in Medical Oncology - nominated by Royal College of Physicians

Dr Anne Thomas, Senior Lecturer in Medical Oncology - nominated by Royal College of Physicians (PDF 19 KB)

Abrar Hussain-Qureshi, Senior Radiographer - nominated by Macmillan Cancer Support

Gastric cancer (advanced) - capecitabine: appendix A - final scope

Gastric cancer (advanced) - capecitabine: appendix B - final matrix

Gastric cancer (advanced) - capecitabine: appendix C - Institute's response to consultee and commentator comments on the draft scope

Gastric cancer (advanced) - capecitabine: appendix D - Institute's response to consultee and commentator comments on the provisional matrix